The 3rd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) Hilton Hotel, Prague, Czech Republic, May 13-16, 2010
Industry Advisory Board (IAB)
We view industry not only as a sponsor of our academic activity but rather as partners that can promote new research and innovative developments that will undoubtedly originate from this challenging meeting of interdisciplinary experts of the highest quality. In addition, the IAB, including representatives of the congress sponsors, is expected to guide the Organizing Committee with innovations and new research that are in demand.     R. Birnboim, Sanofi-Aventis R. Kruidenier, Medtronic K. Brown Frandsen, Novo Nordisk B. Levy, Johnson & Johnson R. Chaiken, Pfizer Z. Milicevic, Eli Lilly E. Fan, Roche S. Nagendran, Daiichi Sankyo A. Gorska, Medtronic R. Niecestro, Accelapharm H. Gringolts, Johnson & Johnson G. Panina, Novartis B. Hirshberg, Astra Zeneca C. Rondinone, Roche H. Katzeff, Merck H. Schwierz, Boehringer Ingelheim F. Kaufman, Medtronic A. Toft, Novo Nordisk H. Khatami, Roche M. Von Eynatten, Boehringer Ingelheim C. Koenen, Novo Nordisk